2382
A. Arcadi et al. / Tetrahedron 66 (2010) 2378–2383
(%)¼345(20) [Mþ], 330 (100). Anal. calcd for C22H19NO3: C 76.42, H
(dec) (cryst from acetone/hexane), were obtained from 106 mg of
3f and 104 mg of 5a. 1H NMR:
5.54, N 4.06. Found C 76.63, H 5.52, N 4.08.
d
¼10.04 (br s, 1H, N–H), 8.40 (s, 1H),
8.29 (s, 1H), 7.11 (t, J¼3.8 Hz, 1H), 2.75–2.64 (m, 6H), 2.29–2.20 (m,
4.4.6. 2-[2-(4-Acetylphenyl)-1H-indol-3-yl]cyclohex-2-en-1-one
(6ca). Yield¼67%; 58 mg of brown solid, mp 194–195 ꢀC (cryst from
acetone/hexane), were obtainedfrom90 mgof3cand67 mgof5a.1H
2H), 1.72–1.60 (m, 2H), 1.41–1.29 (m, 2H), 0.92 (t, J¼7.2 Hz, 3H). 13C
NMR:
d
¼198.1 (C]O), 151.7, 143.6, 141.0, 138.1, 132.5, 129.2, 120.8,
120.2, 115.5, 112.2, 93.5, 38.8, 31.2, 26.7, 26.6, 23.0, 22.4, 13.7. IR
(KBr):
295 (48), 294 (88). Anal. calcd for C19H19N3O3: C 67.64, H 5.68, N
12.46. Found C 67.91, H 5.66, N 12.41.
NMR:
7.34 (d, J¼8.2 Hz, 2H), 7.16 (t, J¼3.9 Hz, 1H), 7.12–7.00 (m, 3H), 2.66–
2.57 (m, 4H), 2.48 (s, 3H), 2.26–2.17 (m, 2H). 13C NMR:
¼198.3,197.6
d¼9.09 (br s,1H, N–H), 7.60 (d, J¼8.2 Hz, 2H), 7.45–7.40 (m,1H),
n
¼3330, 2230, 1670 cmꢂ1. MS (EI): m/z (%)¼337 (100) [Mþ],
d
(C]O),151.0,137.7,136.4,135.5,134.7,133.9,128.7,128.5,126.9,123.0,
120.3, 119.4, 111.2, 39.1, 26.8, 26.5, 23.1. IR (KBr):
n
¼3330, 1670 cmꢂ1
.
4.4.12. 2-[2-(4-Phenylcyclohex-1-en-1-yl)-1H-indol-3-yl]cyclohex-
2-en-1-one (6ia). Yield¼40%; 46 mg of pale grey solid, mp 120–
122 ꢀC (cryst from diethyl ether/hexane), were obtained from
MS (EI): m/z (%)¼329 (100) [Mþ], 286 (17), 272 (72). Anal. calcd for
C22H19NO2: C 80.22, H 5.81, N 4.25. Found C 80.47, H 5.82, N 4.27.
115 mg of 3g and 76 mg of 5a. 1H NMR:
d
¼8.06 (br s,1H, N–H), 7.36–
4.4.7. 2-[2-(2-Bromophenyl)-1H-indol-3-yl]cyclohex-2-en-1-one
(6da). Yield¼87%; 109 mg of pale yellow solid, mp 180–181 ꢀC
(cryst from diethyl ether/hexane) were obtained from 126 mg of 3d
7.21 (m, 7H), 7.17–7.00 (m, 3H), 6.08 (br s, 1H), 2.90–2.75 (m, 1H),
2.65–2.52 (m, 4H), 2.50–2.35 (m, 4H), 2.30–1.95 (m, 4H). 13C NMR:
d
¼198.2 (C]O), 149.3, 146.6, 136.8, 135.4, 135.0, 131.5, 130.6, 129.2,
and 84 mg of 5a. 1H NMR:
d
¼8.23 (br s, 1H, N–H), 7.64 (d, J¼7.7 Hz,
128.4, 126.7, 126.4, 126.2, 122.0, 119.8, 119.0, 110.6, 39.5, 39.1, 33.7,
1H), 7.45–7.30 (m, 3H), 7.24–7.07 (m, 4H), 6.85 (t, J¼4.1 Hz,1H), 2.54
29.9, 28.0, 26.7, 23.2. IR (KBr):
n
¼3335,1660 cmꢂ1. ESI-MS m/z (%):
(t, J¼6.2 Hz, 2H), 2.44–2.35 (m, 2H), 2.11–2.02 (m, 2H). 13C NMR:
368 (100) [Mþþ1]. Anal. calcd for C26H25NO: C 84.98, H 6.86, N 3.81.
d
¼198.0 (C]O), 149.8, 135.5, 134.6, 134.2, 133.3, 132.6, 129.7, 128.9,
Found C 85.23, H 6.89, N 3.80.
128.4, 127.4, 127.2, 123.3, 122.6, 120.2, 120.1, 111.0, 39.0, 26.7, 23.0. IR
(KBr):
n
¼3350, 1650 cmꢂ1. MS (EI): m/z (%)¼367 (87), 365 (87)
Acknowledgements
[Mþ], 286 (100), 272 (72). Anal. calcd for C20H16BrNO: C 65.59, H
4.40, N 3.82. Found C 65.65, H 4.42, N 3.81.
`
This work was financed by the Ministero dell’Universita e della
Ricerca, Rome, and by the University of L’Aquila.
4.4.8. 2-(2-Thien-2-yl-1H-indol-3-yl)cyclohex-2-en-1-one
(6ea). Yield¼95%; 94 mg of brown solid, mp 144–145 ꢀC (cryst
from acetone/hexane), were obtained from 100 mg of 3e and 83 mg
References and notes
of 5a. 1H NMR:
d
¼8.93 (br s, 1H, N–H), 7.31–7.27 (m, 1H), 7.12–7.08
1. Selected current references: (a) Stansfield, I.; Ercolani, C.; Mackay, A.; Conte, I.;
Pompei, M. Bioorg. Med. Chem. Lett. 2009, 19, 627–632; (b) Zhou, N.; Zeller, W.;
Krohn, M.; Anderson, H.; Zhang, J.; Onua, E.; Kiselyov, A. S.; Ramirez, J.; Hall-
dorsdottir, G.; Andre´sson, 5.; Gurney, J.; Singh, M. E. Bioorg. Med. Chem. Lett.
2009, 19, 123–126; (c) Trogden, B. G.; Kim, S. H.; Lee, S.; Katzenellenbogen, J. A.
Bioorg. Med. Chem. Lett. 2009, 19, 485–488; (d) Gurkok, G.; Altanlar, N.; Suzen,
N. S. Chemotherapy 2009, 55, 15–19; (e) Singhl, N.; Kumar Bhati, S.; Kumar, A.
Eur. J. Med. Chem. 2008, 43, 2597–2609; (f) Oslund, R. C.; Cermak, N.; Gelb, M. H.
J. Med. Chem. 2008, 51, 4708–4714.
(m, 2H), 7.04–7.00 (m, 2H), 6.90–6.84 (m, 1H), 6.72–6.70 (m, 1H),
6.62 (t, J¼4.6 Hz, 1H), 2.64 (t, J¼6.2 Hz, 2H), 2.56–2.51 (m, 2H),
2.23–2.10 (m, 2H). 13C NMR:
d
¼198.7 (C]O), 152.2, 135.9, 134.6,
134.4, 129.7, 129.2, 127.3, 124.8, 124.3, 122.5, 119.9, 118.9, 111.1, 39.1,
26.8, 23.0. IR (KBr):
n
¼3320, 1670 cmꢂ1. MS (EI): m/z (%)¼293 (100)
[Mþ], 264 (22), 236 (42). Anal. calcd for C18H15NOS: C 73.69, H 5.15,
N 4.77. Found C 73.43, H 5.13, N 4.77.
2. Selected current references: (a) Chen, Y.; Cho, C.-H.; Larock, R. C. Org. Lett. 2009,
11, 173–176; (b) Dooleweerdt, K.; Ruhland, T.; Skrydstrup, T. Org. Lett. 2009, 11,
221–224; (c) Fuwa, H.; Sasaki, M. J. Org. Chem. 2009, 74, 212–221; (d) Huang, H.;
Peters, R. Angew. Chem., Int. Ed. 2009, 48, 604–606; (e) Goverdhan, G.; Reddy, A.
R.; Sampath, A.; Srinivas, K.; Himabindu, V.; Reddy, G. M. Org. Process Res. Dev.
2009, 13, 67–72; (f) Barraja, P.; Diana, P.; Carbone, A.; Cirrincione, G. Tetrahedron
2008, 64, 11625–11631; (g) Frayne, G. L.; Green, G. M. Tetrahedron Lett. 2008, 49,
7328–7329; (h) Inamoto, K.; Saito, T.; Hiroya, K.; Doi, T. Synlett 2008, 3157–
3162; (i) Sanz, R.; Guilarte, V.; Castroviejo, M. P. Synlett 2008, 3006–3010; (j) Xu,
4. 4. 9. 2-(2-Butyl-1H-indol- 3-yl)cyclohex-2-en-1-one
(6fa). Yield¼77%; 81 mg of pale yellow solid, mp 91–93 ꢀC (cryst
from diethyl ether/hexane), were obtained from 106 mg of 3f and
96 mg of 5a. 1H NMR:
7.24–7.19 (m, 1H), 7.09–7.00 (m, 3H), 2.68–2.53 (m, 6H), 2.21–2.09
d
¼8.10 (br s, 1H, N–H), 7.33–7.28 (m, 1H),
¨
Z.; Hu, W.; Zhang, F.; Li, Q.; LU, Z.; Zhang, L.; Jia, Y. Synthesis 2008, 3981–3987;
(m, 2H), 1.65–1.49 (m, 2H), 1.40–1.22 (m, 2H), 0.88 (t, J¼7.2 Hz, 3H).
13C NMR:
d
¼198.5 (C]O), 149.5, 137.5, 135.2, 134.5, 129.0, 128.4,
(k) Li, P.; Wang, L.; Wang, M.; You, F. Eur. J. Org. Chem. 2008, 5946–5951; (l)
Melkonyan, F.; Topolyan, A.; Yurovskaya, M.; Karchava, A. Eur. J. Org. Chem.
2008, 5952–5956; Ling, R.; Yoshida, M.; Mariano, P. S. J. Org. Chem. 1996, 61,
4439–4449.
121.0, 119.4, 118.6, 110.5, 39.1, 31.6, 29.7, 26.7, 23.3, 22.4, 13.8. IR
(KBr):
n
¼3310, 1660 cmꢂ1. MS (EI): m/z (%)¼267 (100) [Mþ], 224
¨
3. Recent reviews: (a) KrUger, K.; Tillack, A.; Beller, M. Adv. Synth. Catal. 2008, 350,
(98), 196 (41). Anal. calcd for C18H21NO: C 80.86, H 7.92, N 5.24.
Found C 81.11, H 7.88, N 5.22.
2153–2167; (b) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873–2920.
4. (a) Arcadi, A.; Bianchi, G.; Inesi, A.; Marinelli, F.; Rossi, L. Eur. J. Org. Chem. 2008,
783–787; (b) Koradin, C.; Dohle, W.; Rodriguez, A.; Schmid, B.; Knochel, P.
Tetrahedron 2003, 59, 1571–1587.
5. (a) Suzuki, N.; Yasaki, S.; Yasuhara, A.; Sakamoto, T. Chem. Pharm. Bull. 2003, 51,
1170–1173; (b) Yasuhara, A.; Suzuki, N.; Yoshino, T.; Takeda, Y.; Sakamoto, T.
Tetrahedron Lett. 2002, 43, 6579–6582; (c) Yasuhara, A.; Kanamori, Y.; Kaneko,
M.; Numata, A.; Kondo, Y.; Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 1999,
529–534.
6. (a) Okuma, K.; Seto, J.-i.; Sakaguchi, K.-i.; Ozaki, S.; Nagahora, N.; Shioji, K.
Tetrahedron Lett. 2009, 50, 2943–2945; (b) Sakai, N.; Annaka, K.; Fujita, A.; Sato,
A.; Konakahara, T. J. Org. Chem. 2008, 73, 4160–4165; (c) Clentsmith, G. K. B.;
Field, L. D.; Messerle, B. A.; Shasha, A.; Turner, P. Tetrahedron Lett. 2009, 50,
1469–1471; (d) Arcadi, A.; Bianchi, G.; Marinelli, F. Synthesis 2004, 610–618.
7. (a) Praveen, C.; Wilson Sagayaraj, Y.; Perumal, P. T. Tetrahedron Lett. 2009, 50,
644–647 and references therein; (b) Arcadi, A.; Alfonsi, M.; Bianchi, G.; D’An-
niballe, G.; Marinelli, F. Adv. Synth. Catal. 2006, 348, 331–338.
8. Cacchi, S.; Marinelli, F. In Handbook of Organopalladium Chemistry for Organic
Synthesis; Negishi, E. I., Ed.; John Wiley & Sons: New York, NY, 2002; Vol. 2,
pp 2227–2244.
9. (a) Cacchi, S.; Fabrizi, G.; Goggiamani, A. Adv. Synth. Catal. 2006, 348, 1301–
1305; (b) Cacchi, S.; Fabrizi, G.; Lamba, D.; Marinelli, F.; Parisi, L. M. Synthesis
2003, 728–734; (c) Arcadi, A.; Cacchi, S.; Marinelli, F. Tetrahedron Lett. 1992, 33,
3915–3918.
4.4.10. 2-[2-(4-Acetylphenyl)-5,7-difluoro-1H-indol-3-yl]cyclohex-2-
en-1-one (6ga). Yield¼72%; 95 mg of pale yellow solid, mp 195–
195 ꢀC (cryst from acetone/hexane), were obtained from 132 mg of
3g and 88 mgof 5a.1H NMR:
d
¼8.59 (br s,1H, N–H), 7.93 (d, J¼8.4 Hz,
2H), 7.54 (d, J¼8.4 Hz, 2H), 7.06 (t, J¼4.0 Hz, 1H), 6.84 (d, J¼8.6 Hz,
1H), 6.77–6.67 (m,1H), 2.66–2.52 (m, 4H), 2.60 (s, 3H), 2.22–2.15 (m,
2H). 13C NMR (500 MHz):
d¼197.2, 196.6 (C]O), 156.6 (dd,
J1¼238.1 Hz, J2¼10.0 Hz), 150.7, 147.8 (dd, J1¼247.0 Hz, J2¼13.9 Hz),
135.9, 135.53, 135.49, 133.2, 130.8 (dd, J1¼10.6 Hz, J2¼5.9 Hz), 128.1,
126.2,120.4 (d, J¼13.5 Hz), 99.7 (dd, J1¼23.9 Hz, J2¼4.0 Hz), 97.6 (dd,
J1¼30.2 Hz, J2¼20.3 Hz). IR (KBr):
n
¼3310,1670 cmꢂ1. MS (EI): m/z
(%)¼365 (100) [Mþ], 308 (79). Anal. calcd for C22H17F2NO2: C 72.32, H
4.69, N 3.83. Found C 72.08, H 4.69, N 3.85.
4.4.11. 2-Butyl-5-nitro-3-(6-oxocyclohex-1-en-1-yl)-1H-indole-7-
carbonitrile (6ha). Yield¼60%; 63 mg of yellow solid, mp>230 ꢀC